Adipose-derived stem cells (ASCs) represent a promising tool for soft tissue engineering as
well as for clinical treatment of inflammatory and autoimmune pathologies. The well …

Mesenchymal stem/stromal cells (MSC) show widespread application for a variety of clinical
conditions; therefore, their use necessitates continuous monitoring of their safety. The risk …

Background Mesenchymal stem (stromal) cells (MSCs) mediate their immunoregulatory and
tissue repair functions by secreting paracrine factors, including extracellular vesicles (EVs) …

Accumulating evidence shows that extracellular vesicles (EVs) produced by mesenchymal
stem/stromal cells (MSCs) exert their therapeutic effects in several disease models. We …

Stem cell-based and stem cell-derived exosome-based therapies have shown promising
potential for endometrial regeneration and the clinical treatment of intrauterine adhesions …

Background Exosomes derived from stem cells have been widely studied for promoting
regeneration and reconstruction of multiple tissues as “cell-free” therapies. However, the …

In the past decades, continuous effort has been paid to deeply understanding the
pathophysiology of inflammatory bowel diseases (IBD), such as ulcerative colitis or Crohn's …

Aim To investigate the potential of an ultrashort aromatic peptide hydrogelator integrated
with hyaluronic acid (HA) to serve as a scaffold for bone regeneration. Materials and …

Stem cell therapy is a promising strategy for tissue regeneration. The therapeutic benefits of
cell therapy are mediated by both direct and indirect mechanisms. However, the application …

As emerging therapeutic factors, extracellular vesicles (EVs) offer significant potential for
myocardial infarction (MI) treatment. Current delivery approaches for EVs involve either intra …